P6 Relative lung availability and total systemic exposure after inhalation of medium or high strength doses of beclometasone dipropionate/formoterol fumarate, formulated as pMDI with a next generation propellant
Year: 2025
Type: conference-paper
Study design: Clinical Trial
Authors: M Almeida, M Salvadori, M Corradi, T De Ridder, N Praet, I Viaud, G Varoli, L Girardello, F Sandri, G Cappellini, LV Viganò, KS Mathews, G Poli
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416101797
